Company Overview of Bayer HealthCare AG
Bayer HealthCare AG discovers, develops, manufactures, and markets products that help to prevent, diagnose, and treat diseases for humans and animals worldwide. The company operates through four divisions: Animal Health, Consumer Care, Medical Care, and Pharmaceuticals. The Animal Health division produces and distributes various animal health and care products, which include flea and tick-control solutions, anti-infective products, and endoparasitics for farm and companion animals. The Consumer Care division offers over-the-counter products, such as analgesics, gastrointestinal products, dermatological/topical products, cough and cold remedies, and multivitamins and dietary supplements. It s...
Building Q 30
Founded in 1863
Key Executives for Bayer HealthCare AG
Chairman of Management Board
Chief Financial Officer and Head of Central Administration & Organization
Head of Product Supply and Member of Management Board
Chief Operating Officer of Bayer CropScience and Member of Executive Committee
Head of Global Drug Discovery
Compensation as of Fiscal Year 2014.
Bayer HealthCare AG Key Developments
HealthCare Reports Earnings Results for the First Quarter of 2015
Apr 30 15
HealthCare reported earnings results for the first quarter of 2015. For the quarter, sales increased by 7% to EUR 5.7 billion. Adjusted EBITDA increased by 24% to EUR 1.6 billion. The strong business performance, the contributions from the acquired businesses and positive currency effects of approximately EUR 50 million drove the improvement in earnings. Earnings growth was held back by increased investments in R&D as well as increased expenses from marketing and sale.
Bayer HealthCare Reports China Sales Results for the Year 2014
Apr 30 15
Bayer HealthCare reported china sales results for the year 2014. For the year, the company reported EUR 1.659 billion or CNY 13.55 billion sales value in China in 2014, rising 14% from a year earlier. Sales value for healthcare prescription drugs hiked 15% and that for health consumer and animal health products increased 26% and 11%.
Bayer HealthCare to Close St. Joseph Animal Health Plant
Apr 21 15
Bayer HealthCare will close its manufacturing operations in St. Joseph in June. Production of two animal health product lines that had been made in the city will move to Bayer's Shawnee campus. The company announced in February that it would attempt to sell its St. Joseph manufacturing facilities and some of the products made there. It plans to retain a distribution center in the city. The company stressed that its decision to close the St. Joseph site was not a reflection on employees. Rather, changes in the market created excess demand. Workers affected by the closing will receive information on job opportunities at other Bayer facilities. Bayer plans to continue producing the DVM and Expert Care brands. The company will discontinue other products that had been made in St. Joseph.
Similar Private Companies By Industry
Recent Private Companies Transactions
Most Searched Private Companies
Sponsored Financial Commentaries